Three adult patients with de novo acute myeloid leukemia of distinct subtypes harboring t(11;12)(p15;q13) have been investigated to characterize the genes involved in that translocation. Through molecular cytogenetics, a chromosome break was detected at the 3 0 part of nucleoporin 98 (NUP98) gene at 11p15. Using rapid amplification of cDNA end, we identified the partner gene at 12q13, HOXC11. Molecular analysis showed that exon 12 of NUP98 was fused in-frame to exon 2 of HOXC11 in all three cases with t(11;12)(p15;q13). Therefore, this type of fusion may represent the major form of the NUP98-HOXC11 chimera so far reported. Moreover, two out of three cases had a confirmed deletion of the 3 0 part of NUP98 gene and more telomeric region of 11p harboring a group of tumor-suppressor genes. Interestingly, the NUP98-HOXC11 protein when assayed in a GAL4 reporter system, showed an aberrant trans-regulatory activity as compared to the wild-type HOXC11 in both COS-7 and HL-60 cells. Therefore, NUP98-HOXC11 may contribute to the leukemogenesis by interfering with the cellular mechanism of transcriptional regulation.
Introduction
Specific chromosomal translocations in hematological malignancies, especially those with resultant chimeric genes, are of great significance for understanding not only pathogenesis of leukemia but also physiological functions of the genes involved. Nucleoporin 98 (NUP98) is a component of the nuclear pore complex (NPC), which conducts RNA and protein traffic between the nucleus and cytoplasm. NUP98 contains a domain with multiple FG repeats (including FG, FXFG or GLFG), providing docking sites for nuclear transport, an important physiological process for cell life. 1, 2 However, NUP98 calls universal attention for its potential in leukemogenesis as a promiscuous gene fusing with a number of genomic sites. 3 To date, at least 14 partner genes have been reported being involved in translocations with NUP98 as the common target. They are HOXA9, DDX10, HOXD13, PMX1, RAP1GDS1, TOP1, LEDGF, NSD1, HOXD11, HOXA11, NSD3 , HOXA13, HOXC11 and HOXC13. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] It has been well established that the homeobox genes, encoding an evolutionarily well-conserved family of transcription factors, are vital in organogenesis as well as tumorigenesis. 18, 19 As a representative type of homeobox genes, HOX gene family members share the homeodomain (HD) with helix-turn-helix tertiary structure. A large body of evidence suggests that HOX family proteins heterodimerize, through HD, with other HD proteins to bind sequence-specific DNA, resulting in activation or repression of target genes. This phenomenon is consistent with the fact that different organs display a specific combination of HOX gene expression. [20] [21] [22] [23] In the present work, we are able to show that the NUP98-HOXC11 chimeric gene is a recurrent genetic event in acute myeloid leukemia(AML). More importantly, we identified the fusion between exon 12 of NUP98 and exon 2 of HOXC11 to be the major form of this gene rearrangement and revealed its aberrant trans-regulatory activity.
Materials and methods

Case history
Three patients with AML and t(11;12)(p15;q13) chromosomal translocation were selected, and their clinical, hematological and cytogenetic data are summarized in Table 1 . In fact, the clinical data of case 3 were previously reported, but recently reanalyzed according to the WHO classification of leukemia.
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Cytogenetic analysis
Chromosomes were R-banded on unstimulated bone marrow (BM) cells after 24 h culture. Karyotypes were classified according to International System for Human Cytogenetic Nomenclature. Chromosome painting (CP) was performed by using whole CP probes for chromosome 12 (digoxigeninlabeled, Oncor, USA) and chromosome 11(biotin-labeled, Cambio, UK). For fluorescence in situ hybridization (FISH) analysis, several BAC/PAC clones (Invitrogen, Carlsbad, CA, USA), were selected, labeled with biotin or digoxigenin (Roche, Indianapolis, USA) and applied to the disrupted region, including BAC RP11-496I9 (AC021663), BAC RP11-532E4 (AC061979), PAC PDJ 1075f20 (AC 002536), BAC RP11-113A6 (AC 026645), BAC RP11-555F1 (AC16765), BAC RP11-120E20 (AC060812) at 11p15 from telomere to centromere, and BAC RP11-972K6 (AC073594) at 12q13. All procedures were performed according to the manufacturer's recommendations.
RNA isolation
Mononuclear cells (MNC) were obtained from BM samples of patients by Ficoll density centrifugation, and were frozen and stored in liquid nitrogen. Total RNA was extracted from the stored MNC samples using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) RNA was quantitated, aliquoted and stored at À701C for further use.
Analysis of genomic DNA fragments spanning NUP98-HOXC11 breakpoints
High molecular weight genomic DNA was extracted from frozen leukemia cells. Genomic DNA (10 mg) was digested, respectively, with BamHI and BglII restriction enzymes, separated by 0.7% agarose gel electrophoresis, transferred onto a Hybond-XL membrane (Amersham-Pharmacia, Uppsala, Sweden). Hybridization with a-32 P-dCTP-labeled probe was performed at 681C in ExpressHyb Hybridization Solution (Clontech). Autoradiography was performed using Molecular Imager FX System (Bio-Rad). A cDNA fragment covering exons 11-14 of NUP98 gene was used as a probe to detect NUP98 rearrangement.
cDNA cloning of the NUP98 fusion partner gene
0 -rapid amplification of cDNA end (RACE) was performed using the 3 0 -RACE system (Invitrogen) with NUP98 gene specific primers N-1 (5 0 -GTGCACCTTCATTTGGTACAACC-3 0 ) and N-2 (5 0 -CTCTTGGTGCTGGACAGGCATC-3 0 ) and adaptor primers AP (5 0 -GGCCACGCGTCGACTAGTAC(T) 17 -3 0 ) and UAP (5 0 -(CUA) 4 GGCCACGCGTCGACTAGTAC-3 0 ). The 3 0 -RACE products were separated by electrophoresis and subcloned into the pGEMT-easy vector (Promega, Madison, WI, USA). The plasmid clones were sequenced using a Sequence dye terminator cycle sequencing kit (Perkin-Elmer, Foster City, CA, USA).
Reverse transcription-polymerase chain reaction (RT-PCR)
Reverse transcription was performed on 1 mg of total RNA. After 10 min at 251C, RNA was incubated for 50 min at 451C with 50 U of Superscript II Reverse transcriptase (Invitrogen), 20 U of RNase inhibitor (Invitrogen), 2.5 mM random hexamers and dNTP at 0.5 mM in a final volume of 20 ml. Then, the reverse transcriptase was denatured by heating for 5 min at 851C. A volume of 2 ml of the reverse transcription product was used for PCR. PCR amplification was carried out for 35 cycles (denaturation at 941C for 25 s, annealing at 571C for 45 s and elongation at 721C for 60 s), followed by predenaturation at 941C for 5 min and elongation at 721C for 10 min) using a GeneAmp PCR system 9600 (Perkin-Elmer). For NUP98-HOXC11 transcript, the primers were N-1 and H-1 (5 0 -TTACAGCAGAGGATTTCCCG-3 0 ). For the reciprocal HOXC11-NUP98 transcript, the primers were N-3 (5 0 -CTAGGGATGGTT CATCGTC-3 0 ) and H-2 (5 0 -ATGGATCCATGTTTAACTCGGTC AACCT-3 0 ). The PCR products were separated by electrophoresis and sequenced. To confirm the accuracy of the RT-PCR results, Southern analysis of the PCR products was performed using the oligonucleotide probes P1 (corresponding to the joining of NUP98 exon 12 to HOXC11 exon 2) and P2 (corresponding to the theoretical joining of HOXC11 exon 1 to NUP98 exon 13) labeled with g-32 P-ATP using T4 polynucleotide kinase.
Construction of expression plasmids
cDNAs containing full-length NUP98-HOXC11, wild-type HOXC11 and HOXC11-HD (only containing HD of HOXC11 gene) coding sequences were obtained by RT-PCR on RNA samples extracted from leukemia cells of patients and Hela cell line, respectively. The wild-type NUP98 cDNA was kindly provided by Dr van Deursen JM (Department of Pediatrics and Adolescent Medicine, Rochester, USA). The 5 0 and 3 0 primers used for PCR contained unique BamH1 and Not1 restriction sites to facilitate cloning into the pBIND plasmid (Promega) inframe with sequences encoding the GAL4 DNA-binding domain.
Cell culture and transient transfection assay
COS-7 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS), while HL-60 cells were cultured in RPMI-1640 medium with 10% FBS. For transient transfection, the cells were placed in sixwell plates for 24 h and were then transfected with 1 mg of each pBIND fusion plasmid, 1 mg 5Â GAL4-pG5-luc (Promega) plasmid, and 0.1 mg pRL-SV40 plasmid (Promega) using SuperFect transfection reagent (QIAGEN, German) according to the manufacturer's recommendations. Cells were harvested 36 h after transfection. Luciferase activity was measured in a luminometer with Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer ' s protocol. Each transfection was performed in duplicate and repeated three times. Reporter gene-derived firefly luciferase activity was then normalized to Renilla luciferase derived from pRL-SV40.
Results
Region containing NUP98 gene was disrupted by t(11;12)(p15;q13)
The results of the cytogenetic analysis of R-banding on BM cells from three cases revealed a t(11;12)(p15;q13) ( Table 1 , a representative karyotype of case 1 being shown in Figure 1a) . In case 1, CP analysis further confirmed the translocation between chromosomes 11 and 12 ( Figure 1b) . Although FISH analysis with BAC RP11-120E20 containing the NUP98 gene showed two pairs of signals, the intensity of the signals on normal chromosome 11 being much stronger than those of the der(11) (Figure 1c ). On the other hand, FISH analysis with clones at distal region of chromosome 11, such as BAC RP11-496I9, BAC RP11-532E4, BAC RP11-113A6, BAC RP11-555F1 and PAC PDJ 1075f20, showed only one pair of signals (Figure 1d ), in contrast to two pairs in normal control (Figure 1e ). We speculated two interrelated events in this case: a translocation t(11;12)(p15;q13) disrupting the NUP98 gene and a deletion of distal region downstream of the chromosomal break on der (11) . The molecular cytogenetic analysis of case 2 was consistent with that of case 1 (data not shown).
Genomic structure of the t(11;12)(p15;q13) translocation breakpoints
To confirm that NUP98 was directly involved in the t(11;12)(p15;q13), Southern analysis was conducted on NUP98 gene. As shown on Figure 2 , a cDNA probe encompassing exons 11-14 revealed a rearranged band in BglIIdigested DNA from case 1, whereas no abnormal bands were detected in DNA analyzed by BamHI. Restriction mapping thus located the breakpoint to intron 12 of the NUP98 (Figure 2a) .
It was reasoned that if this rearrangement resulted from a gene fusion, then exon 12 of NUP98 should be joined to the partner gene.
Cloning of fusion transcripts in t(11;12)(p15;q13) leukemia patients Next, a 3 0 -RACE was performed to determine the partner gene fused to NUP98 gene, most likely on chromosome 12q13. A RACE product of about 400 bp was identified. Sequence analysis revealed that the 5 0 portion of RACE product was a part of the cDNA sequence of NUP98 gene, while the 3 0 portion was a part of the cDNA sequence of HOXC11 gene on chromosome 12q13 (Figure 3a) . Importantly, the fusion was an in-frame one between exon 12 of the NUP98 gene and exon 2 of HOXC11 gene (Figure 3a) . Next, a BAC clone RP11-972K6 corresponding to the HOXC11 displayed fused signal to that of NUP98 in FISH analysis (Figure 1f) . Subsequently, using appropriate primers, we amplified the whole NUP98-HOXC11 fusion transcript, which includes the N-terminal FG domain of the NUP98 and the C-terminal HD of HOXC11 gene (Figure 3b ).
Examination of NUP98-HOXC11 fusion gene in patients with t(11;12)
To examine if NUP98-HOXC11 transcripts existed in other two patients (cases 2 and 3) with t(11;12)(p15;q13), RT-PCR was carried out to amplify the fusion region, which was then subject to Southern analysis with specific oligonucleotide probes. The result showed that these two patients, like case 1, also had NUP98-HOXC11 transcripts and the fusion occurred exactly between NUP98 exon 12 and HOXC11 exon 2 (Figure 3c ). Of note, no reciprocal HOXC11-NUP98 transcript could be obtained among all three patients in this series (Figure 3c ).
N-terminal of NUP98 modulates the trans-regulatory activity of HOXC11
Since HOXC11 is an important transcription factor, its fusion to NUP98 may change the biological functions in terms of the regulation of the downstream genes. Since the target genes physiologically regulated by HOXC11 have not yet been reported, we were not able to construct a reporter system with HOXC11 binding sites. In addition, a reporter construct with PBX1-HOXA9 binding motifs showed no response to HOXC11 in transient transfection assay (data not shown). Hence, an artificially constructed system used by several groups in previous studies on NUP98-related fusion genes was also used in the present work to address the trans-regulatory activities of NUP98-HOXC11. We therefore prepared a series of expression vectors in which the GAL4 DNA-binding domain was in-frame fused to NUP98-HOXC11, NUP98, HOXC11 and HOXC11-HD, and then tested the trans-regulatory effect of these constructs on luciferase-based GAL4 reporter system in COS-7 cells and the myeloid cell line HL-60, respectively. Similar to the previous report of the HOXA9 and PMX1, wild-type HOXC11 construct exhibited strong trans-repressing activity in GAL4 reporter system. 7, 37 Apparently, this trans-repressive activity mainly resulted from the C-terminal homeodomain of HOXC11, according to the data of HOXC11-HD. However, NUP98-HOXC11 behaved more likely as a trans-activator, since it drove higher reporter gene expression than the control (Figure Table 1 Clinical data of three cases with t(11;12)(p15;q13) Case no. NUP98/HOXC11 fusion in AML B-W Gu et al 4a and b). That NUP98-HOXC11 could deviate the transrepressing activity of HOXC11 was further confirmed by the cotransfection assays of both plasmids (Figure 4a ). Of note, the wild-type NUP98, when fused with GAL4 DNA-binding domain, showed a strong trans-activating property. It is possible that the altered trans-regulatory activity of fusion protein be caused by the addition of N-terminal portion of NUP98.
Discussion
In this work, we identified, through positional candidate strategy, the NUP98-HOXC11 fusion as a result of the t(11;12)(p15;q13) in three adult AML patients, confirming that this molecular abnormality is a recurrent genetic event in human leukemogenesis. However, the phenotypes of these three cases belonged to two quite distinct subtypes of AML, two with AML-M2 and one with AML-M5, implying that NUP98-HOXC11 fusion could be a relatively late event in the leukemogenic process. Of note, the chimeric protein in our three cases all resulted from a fusion between exon 12 of NUP98 and exon 2 of HOXC11, contrarily to a very recently reported pediatric AML patient with NUP98-HOXC11 in whom the break on chromosome 12 was located within the 3 0 end of the exon 1 of HOXC11. 16 In that particular case, to salvage the otherwise disrupted ORF, a complex mechanism was involved where a stretch of DNA sequence from intron 12 of NUP98, immediately upstream of the truncated exon 1 of HOXC11, was spliced into the fusion transcript.
It is well known that in leukemia, reciprocal or balanced translocations account for most of the chromosomal translocations, while nonreciprocal or unbalanced ones are rare. Of particular note is that the distal portion of the breakpoints on chromosome 11p in two cases (cases 1 and 2) here studied was deleted at molecular cytogenetic level. The absence of the HOXC11-NUP98 fusion transcript in all three patients further supports this observation. Therefore, the t(11;12)(p15;q13) in most patients should be an unbalanced translocation. It is interesting to point out that the lost part in our cases is an important region of tumor-suppressor gene (TSG). At least six TSGs have been found at 11p15.5, namely TSSC1-6. FISH analysis with BAC RP11-555F1, containing TSSC3, revealed only one pair of signals in case 1, on the contrary to two pairs of signals in normal control, confirming a loss of this TSG. The fact that a recently reported NUP98-HOXC13 fusion gene cloned from a patient with t(11;12)(p15;q13) was also accompanied by Conventional and molecular cytogenetic analysis of case 1. (a) Representative karyotype showing t(11;12)(p15;q13). (b) CP analysis of the metaphase. The red arrow indicates der(11) and the green arrow indicates der (12) . The chromosomes displaying only red color and green color (yellow arrows) are normal chromosomes 11 and 12, respectively. (c) FISH signals of BAC RP11-120E20 containing NUP98 gene were observed on normal chromosome 11 and der (11) . Note the intensity of the signals on normal chromosome 11(opened arrow) was much stronger than that on der(11) (filled arrow). (d) FISH analysis with PAC1075f20 located downstream of chromosome 11 breakpoint showed signals only on normal chromosome 11 but not on der (11) . (e) FISH analysis with the same probe as in (d) showed signals on both normal chromosome 11 in control sample. (f) FISH analysis using probes containing both NUP98 (green) and HOXC11 (red) showed fusion signals (arrows) in interphases in case 1.
NUP98/HOXC11 fusion in AML B-W Gu et al a deletion of the reciprocal fusion gene, 17 suggests that this concomitant event may be the basis for future work in translocation involving NUP98 gene. The situation is also reminiscent of another nonreciprocal translocation found in alveolar soft part sarcoma, a rare solid tumor, with der(17)t(X;17)(p11.2;q25) and the resultant ASPL-CTFE3 fusion gene. 26, 27 Of note, a TSG was lost at 17q25.3-qter. Interestingly, a balanced t(X;17)(p11.2;q25) with ASPL-CTFE3 fusion gene was found in papillary renal adenocarcinomas. 28, 29 It is postulated that the selective pressure for an unbalanced translocation might be a result of loss of those tumor suppressors. We therefore hypothesize that the deletion of the telomeric region on chromosome 11p accompanying t(11;12)(p15;q13) may also contribute to the pathogenesis in those leukemia patients.
The discovery of HOXC11 as a novel biological factor to be reckoned with in leukemogenesis further strengthens the concept that abnormal transcriptional regulation plays a key role in malignant transformation. It has been shown that most HOX gene family members including HOXC11 are transcription repressors. [30] [31] [32] Expression of several HOX genes (located on HOXA and HOXB loci) varies with hematopoietic stem cell differentiation, suggesting a lineage determination function of these genes. The interesting point for HOX genes to be involved in oncogenesis is that the molecular mechanisms could be either deregulation of structurally normal protein or formation of chimeric genes. 33 For example, altered expression of these genes was demonstrated in the involvement of leukemogenesis and some HOXC genes are involved in lymphomagenesis. 34 Moreover, overexpression of HOXC11 was reported previously in aplasia/hypoplasia of the fibula and severe malformations of the appendicular skeleton in mice. 35 On the other hand, the fusion of HOX gene to the NUP98 represents a distinct mechanism in disturbing the cellular program of transcription. In NUP98-HOXA9 fusion, the prototype fusion protein involving a component of NPC and a HOX family member, the transrepression activity of HOXA9 was modified and the fusion protein showed some trans-activating effect over target genes in some experimental settings. 36 Here we show that, as in the case of the NUP98-HOXA9 fusion, linking NUP98 to HOXC11 changes HOXC11 into an activator. It was suggested that NUP98/HOXC11 fusion in AML B-W Gu et al NUP98 is able to bind some components of nuclear receptor coactivator (CoA) complex, such as CBP. 37 The fusion of NUP98 to HOX family member therefore provides the access to the CoA activity. It is nonetheless worth pointing out that most of the results showing trans-activating activity of NUP98-HOX fusion were obtained using GAL4 fusion system, while few experiments were designed to address the trans-regulatory properties of the chimeric proteins on physiological promoters in human being. Of course, the potential precise mechanism of leukemogenesis by NUP98-HOXC11 fusion protein will be better studied by transgenic mouse model experiment.
